NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:17
NeurAxis Profit Margin (Quarterly) : -108.1% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -108.1% |
| March 31, 2026 | -109.5% |
| December 31, 2025 | -176.5% |
| September 30, 2025 | -261.6% |
| June 30, 2025 | -189.1% |
| March 31, 2025 | -254.4% |
| December 31, 2024 | -190.2% |
| September 30, 2024 | -263.3% |
| June 30, 2024 | -477.1% |
| Date | Value |
|---|---|
| March 31, 2024 | -328.0% |
| December 31, 2023 | -999.7% |
| September 30, 2023 | -1.81K% |
| June 30, 2023 | -346.1% |
| March 31, 2023 | -270.0% |
| December 31, 2022 | -2.22% |
| June 30, 2022 | -222.2% |
| March 31, 2022 | -69.99% |
| December 31, 2021 | -182.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.07% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -2.47% |
| AtriCure, Inc. | 2.63% |
| Baxter International, Inc. | 10.01% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -171.2% |
| Return on Assets | -101.0% |
| Return on Invested Capital | -157.6% |
| Gross Profit Margin (Quarterly) | 85.87% |
| Operating Margin (Quarterly) | -110.2% |
| Return on Net Operating Assets | -671.9% |